A New Approach to V-A ECMO Device

Sunday, March 9, 2025

3:35 PM – 3:43 PM ET

Speaker(s)

Tim A. Fischell, MD, FACC

Director of Cardiovascular Research
Ascension Borgess Heart Institute
Kalamazoo, Michigan, United States

Disclosure(s): Ablative Solutions, Inc.: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Salary (Ongoing), Stock-privately held company (Ongoing); Cordis, Endovascular Division: Royalties (Ongoing); Vantis Vascular, Inc.: Employee (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Salary (Ongoing), Stock-privately held company (Ongoing)

Disclosure(s):

Tim A. Fischell, MD, FACC: Ablative Solutions, Inc.: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Salary (Ongoing), Stock-privately held company (Ongoing); Cordis, Endovascular Division: Royalties (Ongoing); Vantis Vascular, Inc.: Employee (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Salary (Ongoing), Stock-privately held company (Ongoing)